{"id":"W2614942658","doi":"10.1016/j.jtho.2017.05.002","title":"EGFR Mutation Analysis for Prospective Patient Selection in Two Phase II Registration Studies of Osimertinib","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; T790M; Afatinib; Gefitinib; Internal medicine; Oncology; Erlotinib; Sanger sequencing; Mutation; Genotyping; Cancer; Epidermal growth factor receptor; Genetics; Genotype; Gene; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01500878,0.0008428796,0.001244662,0.0007280234,0.0008097678,0.001688104,0.0009779168,0.00108516,0.002943402],"category_scores_gemma":[0.009017544,0.0004976179,0.001714619,0.0008205258,0.0005440611,0.001047566,0.0007945604,0.001334687,0.0007297213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008020144,"about_ca_system_score_gemma":0.002077391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006047875,"about_ca_topic_score_gemma":0.001967407,"domain_scores_codex":[0.9953997,0.002536626,0.0006018154,0.0005575333,0.0004569635,0.0004473541],"domain_scores_gemma":[0.995065,0.001997004,0.0009650904,0.0009445703,0.0004983016,0.000529954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1470591,0.002783359,0.6540431,0.0003474441,0.001405407,0.0009919396,0.000742881,0.002468069,0.04274431,0.00148438,0.006503069,0.1394269],"study_design_scores_gemma":[0.04474506,0.04810901,0.802081,0.000186481,0.005150781,0.004307035,0.0006472418,0.01514044,0.04195522,0.00272294,0.03474896,0.000205815],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912155,0.001225732,0.002856865,0.0004520433,0.0001036332,0.001047921,0.001340349,0.00004104375,0.001716912],"genre_scores_gemma":[0.9913337,0.0001955835,0.003627508,0.000483546,0.00004001176,0.0008291564,0.00280351,0.00004235683,0.0006446963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01500878,"threshold_uncertainty_score":0.07937497,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05211197369624498,"score_gpt":0.5453192214811934,"score_spread":0.4932072477849484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}